Literature DB >> 18311784

Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI).

Tatjana Seute1, Pieter Leffers, Guul P M ten Velde, Albert Twijnstra.   

Abstract

BACKGROUND: The aims of this study were to show 1) the effect of changing from computed tomography (CT) to magnetic resonance imaging (MRI) on the prevalence of detected brain metastases (BM) in patients with newly diagnosed small cell lung cancer (SCLC); 2) the difference in survival between patients with single and multiple BM; and 3) the effect of the change in patient labeling on eligibility for prophylactic brain irradiation.
METHODS: From 1980 to 2004, 481 consecutive patients with SCLC were enrolled. Brain imaging was routinely performed after diagnosis of SCLC. At the start of 1991, MRI replaced CT in almost all patients. All patients were regularly examined by a neurologist.
RESULTS: The prevalence of detected BM was 10% in the CT era and 24% in the MRI era. In the CT era, all detected BM were symptomatic, whereas in the MRI era, 11% were asymptomatic. In both periods, patients labeled as single BM survived longer than those labeled as multiple BM. For patients labeled as single BM or multiple BM, survival was longer in the MRI era than in the CT era. The proportion of patients who were eligible for prophylactic cranial irradiation was lower in the MRI era.
CONCLUSIONS: The estimated prevalence of BM increases when MRI is used instead of CT. Patients with a detected single BM survive longer than patients with multiple BM. The apparently increased survival in the MRI era can be attributed to the "Will Rogers phenomenon". The use of MRI makes fewer patients eligible for prophylactic cranial irradiation.

Entities:  

Mesh:

Year:  2008        PMID: 18311784     DOI: 10.1002/cncr.23361

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  48 in total

Review 1.  The role of whole brain radiation therapy for the management of brain metastases in the era of stereotactic radiosurgery.

Authors:  Eisuke Abe; Hidefumi Aoyama
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

2.  Frequency of Silent Brain Metastasis Before Prophylactic Cranial Irradiation in Small Cell Lung Cancer.

Authors:  Ufuk Yılmaz; Esra Korkmaz Kırakli; Ümit Gürlek; Yasemin Özdoğan; Bahri Gümüş; Salih Akşit
Journal:  Turk Thorac J       Date:  2017-01-01

Review 3.  Brain metastases: neuroimaging.

Authors:  Whitney B Pope
Journal:  Handb Clin Neurol       Date:  2018

4.  Surveillance imaging in children with malignant CNS tumors: low yield of spine MRI.

Authors:  Sébastien Perreault; Robert M Lober; Anne-Sophie Carret; Guohua Zhang; Linda Hershon; Jean-Claude Décarie; Hannes Vogel; Kristen W Yeom; Paul G Fisher; Sonia Partap
Journal:  J Neurooncol       Date:  2014-01-09       Impact factor: 4.130

5.  Geometric distortion in magnetic resonance imaging systems assessed using an open-source plugin for scientific image analysis.

Authors:  Takahiro Aoyama; Hidetoshi Shimizu; Ikuo Shimizu; Atsushi Teramoto; Naoki Kaneda; Kazuhiko Nakamura; Masaru Nakamura; Takeshi Kodaira
Journal:  Radiol Phys Technol       Date:  2018-09-25

Review 6.  A review on segmentation of positron emission tomography images.

Authors:  Brent Foster; Ulas Bagci; Awais Mansoor; Ziyue Xu; Daniel J Mollura
Journal:  Comput Biol Med       Date:  2014-04-28       Impact factor: 4.589

7.  Contribution of CSF cytology in the diagnostic work-up of breast cancer patients with neurological symptoms: a retrospective analysis over two decades.

Authors:  C A P Wauters; J Poelen; I Mulder; D Venderink; L J A Strobbe; P Wesseling
Journal:  J Neurooncol       Date:  2012-01-04       Impact factor: 4.130

Review 8.  Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.

Authors:  Michael MacManus; Sarah Everitt; Tanja Schimek-Jasch; X Allen Li; Ursula Nestle; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2017-12

Review 9.  Progress in the management of limited-stage small cell lung cancer.

Authors:  Arya Amini; Lauren A Byers; James W Welsh; Ritsuko U Komaki
Journal:  Cancer       Date:  2013-12-10       Impact factor: 6.860

10.  Central nervous system relapse continues to be a therapeutic challenge in extensive disease small-cell lung cancer patients with initial symptomatic brain metastases and good response to chemoradiotherapy.

Authors:  Farkhad Manapov
Journal:  J Neurooncol       Date:  2009-12-15       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.